PEPperPRINT GmbH, a Heidelberg, Germany-based spin-off of the German Cancer Research Centre, has received a €500,000 start up investment from High-Tech Gründerfonds.
With a proprietary platform technology, the company produces and distributes peptide microarrays on demand, and also provides biotechnology and pharmaceutical industry with screening services based on more complex peptide libraries. The technology is based on a laser printing process.
These peptide microarrays open new biomedical research opportunities by providing individualised, fast and highly efficient solutions for the investigation of proteins, enzymes and antibodies.
The funds will be used to commercialize the company’s product portfolio.